MENU
Dr. Huang was selected as 2021 Outstanding innovative and entrepreneurial Talent
Release date:2021-12-31 15:46:00

2021 Outstanding innovative and entrepreneurial Talents of Zhang Jiang National Innovation Demonstration Area commendation and "Zhang Jiang star" enterprise cultivation communications meeting was successfully held on December 29, 2021. At the meeting, the selection results of the first session which was held by the Construction Office of Shanghai promotion science and technology innovation center and Shanghai Municipal Human Resources and Social Security Bureau were officially announced. Dr. Huang Fei, CEO of Hrain, was successfully selected.                            

Source: Kechuang Shanghai

         

As the main battlefield of the construction of Shanghai Science and technology innovation center, Zhang Jiang Demonstration Area has become the main gathering place of excellent innovation and entrepreneurship talents at home and abroad. The selection of "outstanding innovative and entrepreneurial talents in Zhangjiang national independent innovation demonstration zone" demonstrates Shanghai's determination to adhere to innovation driven development and will encourage more talents to contribute to promoting Shanghai to become a global science and innovation center. 
 

Dr. Huang Fei has many years of experience in cancer drug research and development. In 2015, as a co-founder, Dr. Huang Fei founded Hrain Biotech. After several years of unremitting efforts, he led the team to make solid progress in the R&D and industrialization of tumor cell immunotherapy.
 

In terms of R&D now, Hrain has been approved with four Clinical Trial Permission of class 1.1 new drugs, and has been fully promoted to the stage of registered clinical trial. In terms of industrialization, Hrian independently undertake a national project, high standard R&D platform in Zhang Jiang, and  GMP production base. Which laid a solid foundation for the new R&D pipelines such as CAR-T and CAR-NK, as well as the industrialization of pipelines in clinical trials. 

Dr. Huang was selected as 2021 Outstanding innovative and entrepreneurial Talent
Release date:2021-12-31 15:46:00

2021 Outstanding innovative and entrepreneurial Talents of Zhang Jiang National Innovation Demonstration Area commendation and "Zhang Jiang star" enterprise cultivation communications meeting was successfully held on December 29, 2021. At the meeting, the selection results of the first session which was held by the Construction Office of Shanghai promotion science and technology innovation center and Shanghai Municipal Human Resources and Social Security Bureau were officially announced. Dr. Huang Fei, CEO of Hrain, was successfully selected.                            

Source: Kechuang Shanghai

         

As the main battlefield of the construction of Shanghai Science and technology innovation center, Zhang Jiang Demonstration Area has become the main gathering place of excellent innovation and entrepreneurship talents at home and abroad. The selection of "outstanding innovative and entrepreneurial talents in Zhangjiang national independent innovation demonstration zone" demonstrates Shanghai's determination to adhere to innovation driven development and will encourage more talents to contribute to promoting Shanghai to become a global science and innovation center. 
 

Dr. Huang Fei has many years of experience in cancer drug research and development. In 2015, as a co-founder, Dr. Huang Fei founded Hrain Biotech. After several years of unremitting efforts, he led the team to make solid progress in the R&D and industrialization of tumor cell immunotherapy.
 

In terms of R&D now, Hrain has been approved with four Clinical Trial Permission of class 1.1 new drugs, and has been fully promoted to the stage of registered clinical trial. In terms of industrialization, Hrian independently undertake a national project, high standard R&D platform in Zhang Jiang, and  GMP production base. Which laid a solid foundation for the new R&D pipelines such as CAR-T and CAR-NK, as well as the industrialization of pipelines in clinical trials. 

ABOUT HRAIN
Overview
Awards
Corp Culture
NEWS
Hrain News
Media Library
D & M
Pipeline
R&D
Manufacturing
Clinical Layout
Clinical Center
Talent Construction
Join Us
Training & Development
Life
Contact Us
Contact Us
WE CHAT
WE CHAT
©2016 Hrain Biotechnology Co., Ltd. All rights reserved. Shanghai ICP NO.16016380 MIIT website
©2016 Hrain Biotechnology Co., Ltd. All rights reserved. Shanghai ICP NO.16016380 MIIT website